|
PSMA6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.234400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.595800E-01 |
| Normal-vs-Stage2 |
5.507200E-01 |
| Normal-vs-Stage3 |
3.343800E-01 |
| Normal-vs-Stage4 |
4.566000E-02 |
| Stage1-vs-Stage2 |
9.931800E-01 |
| Stage1-vs-Stage3 |
8.095800E-01 |
| Stage1-vs-Stage4 |
1.580620E-01 |
| Stage2-vs-Stage3 |
8.669600E-01 |
| Stage2-vs-Stage4 |
2.642200E-01 |
| Stage3-vs-Stage4 |
2.043400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.418200E-01 |
| Normal-vs-AfricanAmerican |
5.508800E-01 |
| Normal-vs-Asian |
4.933200E-01 |
| Caucasian-vs-AfricanAmerican |
9.966200E-01 |
| Caucasian-vs-Asian |
9.901000E-01 |
| AfricanAmerican-vs-Asian |
9.961200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.948300E-02 |
| Normal-vs-Female |
3.962200E-01 |
| Male-vs-Female |
1.663800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.604800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.097500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.834440E-01 |
| Normal-vs-Age(81-100Yrs) |
5.003200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.480100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.400000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.171400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.316200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.544200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.054000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.595200E-01 |
| Classical-VS-Follicular |
6.504000E-03 |
| Classical-VS-Other |
1.872390E-01 |
| Classical-VS-Normal |
6.145400E-01 |
| Tall-VS-Follicular |
1.752010E-02 |
| Tall-VS-Other |
1.390840E-01 |
| Tall-VS-Normal |
9.169200E-01 |
| Follicular-VS-Other |
8.890000E-01 |
| Follicular-VS-Normal |
7.839100E-03 |
| Other-VS-Normal |
2.732600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.789800E-01 |
| Normal-vs-N1 |
9.222600E-03 |
| N0-vs-N1 |
5.105800E-02 |
|
|
